Acino Supply

Acino is a Swiss-based pharmaceutical company that specializes in the development, manufacturing, and international distribution of high-quality generic and innovative pharmaceuticals. The company focuses on selected therapeutic areas including gastroenterology, cardiovascular health, and pain management, utilizing advanced drug delivery technologies such as modified-release oral forms and oral dispersible forms. Acino operates as a strategic partner for other pharmaceutical companies through its contract manufacturing and out-licensing business units. Headquartered in Zurich, the company maintains a significant commercial presence in emerging markets across the Middle East, Africa, the CIS region, and Latin America. In 2022, Acino was acquired by ADQ, an Abu Dhabi-based investment and holding company, to bolster its healthcare and life sciences portfolio.